BioCentury
ARTICLE | Company News

ChemDiv, Schering deal

September 19, 2005 7:00 AM UTC

ChemDiv will use its small molecule chemistry capabilities to support SCH's medicinal chemistry programs. Under the two-year deal, SCH will have access to ChemDiv's services, including chemistry devel...